INTRODUCTION
============

Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORP1--11) constitute a large gene family characterized by a C-terminal cholesterol/oxysterol-binding domain ([@B8]; [@B29]; [@B38]; [@B49]). They differentially localize to intracellular membranes and the plasma membrane (PM). Recent studies indicate that ORPs play important roles in nonvesicular transport of cholesterol and other sterols among intracellular organelles. Sterol transport between the PM and the endoplasmic reticulum (ER) in yeast is severely compromised when all seven yeast ORPs are missing ([@B37]). Knockdown of ORP5 causes cholesterol accumulation in late endosomes and lysosomes, which is similar to the cholesterol-trafficking defect observed in Niemann--Pick type C fibroblasts ([@B7]). We also showed that ORPs are required for regulating the cholesterol level in late endosomes/lysosomes in *Caenorhabditis elegans* ([@B17]).

OSBP, a founding member of ORP family, was first identified as a cytosolic receptor for oxysterols such as 25-hydroxycholesterol ([@B46]; [@B6]). OSBP also binds cholesterol and transfers it between liposomes in vitro ([@B30]). In cells, OSBP partitions between the ER and the Golgi ([@B39]) through a "two phenylalanines in an acidic tract" (FFAT) motif that binds vesicle-associated membrane protein--associated protein (VAP) in the ER ([@B50]; [@B24]) and a pleckstrin homology (PH) domain that interacts with phosphatidylinositol-4-phosphate (PI4P) in the Golgi ([@B22]). Knockdown of OSBP decreases the Golgi cholesterol level ([@B2]). Thus it is proposed that OSBP regulates the transport of cholesterol from the ER to the Golgi.

Cholesterol levels are low in the ER, high in the PM, and intermediate in the Golgi ([@B48]; [@B26]). Golgi cholesterol has been implicated in Golgi morphology and function. Cholesterol depletion with methyl-β-cyclodextrin (MβCD) condenses GM130 (a *cis*-Golgi protein) and *N*-acetylglucosaminyl transferase I (a *cis*-Golgi protein) to the perinuclear region ([@B44]), whereas cholesterol loading disperses GM130 and TGN46 (a *trans*-Golgi network protein) throughout the cytoplasm ([@B54]). Vesicular stomatitis virus G transport from the Golgi to the PM is inhibited by either cellular cholesterol depletion or cholesterol loading ([@B44]; [@B54]). Membrane rafts, cholesterol-sphingolipid-protein assemblies, have been postulated to function in post-Golgi membrane trafficking and cargo sorting at the *trans*-Golgi network ([@B42]). In yeast, immunoisolation of post-Golgi vesicles using a raft marker protein as the bait showed that ergosterol, a yeast cholesterol homologue, is selectively enriched in the transport vesicles ([@B16]).

The Golgi is a dynamic polarized organelle that receives cargoes from the ER at the *cis* side and moves them to the *trans* side through the medial compartment ([@B25]). Within the Golgi, the cargoes are modified by glycosidases and glycosyltransferases. These enzymes are nonuniformly distributed within the Golgi stack, allowing sequential modifications of the cargoes ([@B18]). In both yeast and mammalian systems, Golgi enzymes constantly recycle in a retrograde *trans*-to-*cis* manner by means of membrane transport to maintain their abundance and nonuniform distribution ([@B33]; [@B9]). The fusion of recycling transport vesicles with the acceptor membrane requires soluble *N*-ethylmaleimide-sensitive fusion attachment protein receptors (SNAREs), with v-SNAREs on the transport vesicles and target (t)-SNAREs on the acceptor compartment ([@B43]).

In the present study, we find that depletion of OSBP dispersed intra-Golgi v-SNAREs (GS28 and GS15) throughout the cytoplasm without affecting the localization of Golgi t-SNARE syntaxin5 (Syn5), reduced the abundance of a Golgi enzyme, mannosidase II (Man II), and mislocalized the γ-subunit of the coat protein complex I (COP-I; γ-COP) from the Golgi, which is a constituent of COP-I vesicles that participates in intra-Golgi transport. The mislocalization of GS28 and the reduction of Man II in OSBP-depleted cells were largely restored by depletion of ArfGAP1, a regulator of the budding of COP-I vesicles. Our results suggest that the Golgi cholesterol level, which is controlled by OSBP, is essential for the Golgi localization of intra-Golgi v-SNAREs by regulating proper COP-I vesicle transport.

RESULTS
=======

Effect of OSBP depletion on Golgi proteins
------------------------------------------

Because OSBP is primarily associated with the Golgi ([@B39]), we examined the effect of OSBP depletion on the localization and expression of a number of Golgi proteins. OSBP expression was effectively reduced at 72 h after transfection of small interfering RNA (siRNA; OSBP siRNA\#1) in HeLa cells ([Figure 1A](#F1){ref-type="fig"}). We did not find much difference in the localization of Golgi proteins, such as *cis-*Golgi protein GM130, *trans*-Golgi proteins p230 and TGN46, Syn5 (Golgi t-SNARE), and VAMP4 (*trans*-Golgi v-SNARE), between control and OSBP siRNA--treated cells ([Figure 1B](#F1){ref-type="fig"} and Supplemental Figure S1A). In addition, overall protein secretion was normal in OSBP-depleted cells (Supplemental Figure S1B). In contrast, OSBP depletion affected intra-Golgi v-SNAREs (GS28 and GS15). These two v-SNAREs lost their compact perinuclear localization and were dispersed throughout the cytoplasm. The GS28 dispersion occurred in \>70% of OSBP-depleted cells under the present conditions ([Figure 1C](#F1){ref-type="fig"}). The abundance of GS28 did not change ([Figure 1A](#F1){ref-type="fig"}). GS28 and Syn5 form a v-t SNARE complex ([@B12]). The amount of coprecipitation between GS28 and Syn5 in OSBP-depleted cells was reduced compared with that in control cells ([Figure 1D](#F1){ref-type="fig"}), consistent with their different localizations. The abundance of Man II was drastically reduced in OSBP-depleted cells ([Figure 1A](#F1){ref-type="fig"}). Treatment with two other OSBP siRNA oligos resulted in the same phenotype of GS28 mislocalization and Man II reduction (Supplemental Figure S2).

![OSBP depletion mislocalizes intra-Golgi v-SNAREs (GS28 and GS15) throughout the cytoplasm and reduces the level of Golgi enzyme Man II. HeLa cells were transfected with either control or OSBP siRNA (OSBP siRNA\#1). All experiments were performed 72 h after siRNA transfections. (A) Cell lysates were subjected to SDS--PAGE and immunoblotted with the indicated antibodies. (B) Cells were fixed and stained with the indicated antibodies. Scale bar, 10 μm. (C) GS28 localization was examined by immunofluorescence and classified into three categories: 1) perinuclear Golgi localization, 2) Golgi plus cytoplasmic localization, and 3) cytoplasmic localization. More than 40 cells were examined per sample. The data (mean ± SEM) are calculated based on three independent experiments. (D) Coimmunoprecipitation between GS28 and Syn5. Cell lysates were immunoprecipitated with anti-GS28 antibody, and the precipitates were immunoblotted with the indicated antibodies.](3534fig1){#F1}

OSBP mediates sterol-dependent recruitment of ceramide transfer protein (CERT) to the Golgi, resulting in increased ceramide transfer and sphingomyelin synthesis ([@B34]). To test whether the defects in OSBP-depleted cells are due to impaired CERT function, we examined the localization and expression of several Golgi proteins in CERT-depleted cells. CERT was effectively knocked down in cells treated with siRNA\#1 and, to a lesser extent, siRNA\#2 ([Figure 2A](#F2){ref-type="fig"}). CERT depletion resulted in fragmented or loosely packed distributions of Golgi proteins (GM130, TGN46, GS28, and Syn5) at perinuclear area ([Figure 2B](#F2){ref-type="fig"}). The degree of Golgi fragmentation was correlated with that of CERT depletion ([Figure 2, B and C](#F2){ref-type="fig"}). The expression levels of GS28 and Man II were reduced in CERT-depleted cells ([Figure 2A](#F2){ref-type="fig"}). Thus CERT depletion affected differently the localization and expression of Golgi proteins from OSBP depletion. The overexpression of CERT in OSBP-depleted cells did not restore the mislocalization of GS28 ([Figure 2D](#F2){ref-type="fig"}). These results suggest that mislocalization of Golgi v-SNAREs in OSBP-depleted cells is not due to impaired CERT function.

![CERT depletion induces Golgi fragmentation. HeLa cells were transfected with the indicated siRNAs for 72 h. (A) Cell lysates were subjected to SDS--PAGE and immunoblotted with the indicated antibodies. (B) Cells were fixed and stained with anti-GM130 (green) and anti-TGN46 (red) antibodies, or anti-GS28 (green) and anti-Syn5 (red) antibodies. Scale bar, 10 μm. (C) GM130 localization was examined by immunofluorescence, and percentage of cells with partially or totally fragmented GM130 staining was determined. More than 40 cells were examined per sample. The data (mean ± SEM) are calculated based on three independent experiments. (D) HeLa cells were transfected with OSBP siRNA\#1 for 48 h, followed by transfection with the FLAG-tagged CERT plasmid. Seventy-two hours after siRNA transfection, cells were fixed and stained with anti-GS28 (green) and anti-FLAG (red) antibodies. DNA was stained with DAPI (blue). Scale bar, 10 μm.](3534fig2){#F2}

PH domain, FFAT motif, and sterol-binding domain of OSBP are all necessary for the perinuclear Golgi localization of GS28
-------------------------------------------------------------------------------------------------------------------------

OSBP has a PH domain for Golgi targeting, an FFAT motif for ER targeting, a sterol-binding domain, and several phosphorylation sites ([Figure 3A](#F3){ref-type="fig"}). To assess contributions of individual domains to the perinuclear Golgi localization of GS28, we transiently transfected OSBP-depleted cells with Myc-tagged, siRNA-resistant OSBP mutants, including a PI4P-binding--defective mutant (R109/110E; [@B22]), VAP-binding defective mutants (EFFD/ALLA and ∆FFAT; [@B24]), phosphorylation-defective (S381A) and phosphorylation mimic (S381/384/387E) mutants ([@B27]), and a sterol-binding--defective mutant (K495A; [@B13]). Transfection with the siRNA-resistant OSBP wild-type construct (WT\*; [Figure 3B](#F3){ref-type="fig"}) fully restored the perinuclear Golgi localization of GS28 ([Figure 3, C and D](#F3){ref-type="fig"}). The PI4P-binding--defective mutant, the VAP-binding--defective mutants, and the sterol-binding--defective mutant of OSBP did not restore the perinuclear localization of GS28. The expression of WT\*-OSBP also restored Man II expression in OSBP-depleted cells, but the K495A mutant could not (Supplemental Figure S3). These results showed that these three domains of OSBP are all required for the perinuclear localization of GS28. On the other hand, phosphorylation/dephosphorylation of Ser-381, Ser-384, and Ser-387 of OSBP was dispensable because the perinuclear localization of GS28 was restored by the expression of phosphorylation-defective and mimic mutants.

![PH domain, FFAT motif, and sterol-binding domain of OSBP are necessary for perinuclear localization of GS28. (A) Schematic representations of the wild-type (WT) OSBP and OSBP mutants. EQVSHHPP, OSBP signature motif; FFAT, two phenylalanines in an acidic tract motif; SBD, sterol-binding domain. Stars indicate the site of the mutation introduced. (B) HeLa cells were transfected with control or OSBP\#1 siRNA for 48 h, followed by transfection with the indicated plasmids encoding Myc-tagged OSBP or OSBP mutants that contain silent mutations within the siRNA targeting sequence. Seventy-two hours after siRNA transfection, cell lysates were subjected to SDS--PAGE and immunoblotted with anti-OSBP antibody. Transfection with the siRNA-resistant OSBP construct (WT\*) increased OSBP expression close to the normal level. (C, D) Cells were transfected with OSBP\#1 siRNA for 48 h, followed by transfection with the indicated plasmids encoding siRNA-resistant OSBP mutants. Seventy-two hours after siRNA transfection, cells were fixed and stained with anti-GS28 (green) and anti-Myc (red) antibodies. DNA was stained with DAPI (blue). GS28 localization was quantified (C) as in [Figure 1C](#F1){ref-type="fig"}, and representative images are shown (D). Arrows indicate cells with restored perinuclear localization of GS28 by the expression of WT\*, S381A, or S381/384/387E mutants. Scale bar, 10 μm.](3534fig3){#F3}

OSBP depletion affects cholesterol distribution in ER and Golgi
---------------------------------------------------------------

Ridgway and his colleagues showed biochemically that the cholesterol level of endosome/*trans-*Golgi network decreases in OSBP-depleted cells ([@B2]). We took another approach to validate the cholesterol level, using caveolin-1 (Cav1), which accumulates in the Golgi when the cholesterol level in the Golgi is low ([@B35]; [@B5]). In control cells, green fluorescent protein (GFP)--tagged Cav1 (Cav1-GFP) was distributed to the PM and the punctate structures that did not colocalize with GM130 ([Figure 4A](#F4){ref-type="fig"}). In OSBP-depleted cells, Cav1-GFP mostly colocalized with GM130, suggesting that the Golgi cholesterol level is lower than that in control cells. The result provided cell biological evidence that OSBP participates in determining the Golgi cholesterol level. In contrast to OSBP depletion, CERT depletion did not result in Cav1-GFP accumulation at the Golgi ([Figure 4B](#F4){ref-type="fig"}).

![Effect of OSBP depletion on Cav1-GFP localization and ACAT activity. (A) HeLa cells were transfected with control or OSBP\#1 siRNA for 48 h, followed by transfection with the Cav1-GFP plasmid. Seventy-two hours after siRNA transfection, cells were fixed and stained with anti-GM130 (red) and anti-OSBP (blue) antibodies. Arrows indicate Cav1-GFP accumulation in the Golgi of OSBP-depleted cells. Scale bar, 10 μm. (B) HeLa cells were transfected with control or CERT siRNA\#1 for 48 h, followed by transfection with the Cav1-GFP plasmid. Seventy-two hours after siRNA transfection, cells were fixed and stained with anti-GM130 (red) and anti-OSBP (blue) antibodies. Scale bar, 10 μm. (C) Cells were transfected with control or OSBP\#1 siRNA. Seventy-two hours after transfection, the rate of cholesterol esterification in the cells was determined. Data represent mean ± SEM (n = 4). \**p* \< 0.05 vs. control RNA interference.](3534fig4){#F4}

Acyl-CoA:cholesterol acyltransferase (ACAT) is present in the ER, and the activity is positively correlated with the cholesterol concentration in the ER ([@B20]). ACAT activity, as measured by the rate of incorporation of \[^14^C\]oleic acid to cholesteryl esters ([@B10]), was increased by 1.5-fold in OSBP-depleted cells ([Figure 4C](#F4){ref-type="fig"}), suggesting an increase in cholesterol level in the ER. These results, together with the previous findings, indicate that OSBP is involved in the transport of cholesterol from the ER to the Golgi membrane. The finding that the sterol-binding defective mutant (K495A) did not restore the defect in OSBP-depleted cells ([Figure 3, C and D](#F3){ref-type="fig"}) also support this notion.

Effect of cellular cholesterol depletion on Golgi v-SNAREs and Man II
---------------------------------------------------------------------

We then assessed the contribution of cholesterol to the localization and expression of Golgi proteins. Cells were treated for 24 h with lipoprotein-deficient serum (LPDS) plus lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. With this treatment, GS28 was significantly dispersed as OSBP knockdown (Supplemental Figure S4, A and B). Syn5 remained at the perinuclear region, with a slightly dispersed pattern. Because lovastatin affects biosynthesis of dolichol, ubiquinone, and prenylated proteins besides cholesterol biosynthesis, we then used AY9944, a specific inhibitor of 3β-hydroxysterol ∆^7^-reductase that catalyzes the conversion of 7-dehydrocholesterol (7-DHC) to cholesterol ([@B14]). Cells were treated for 48 h with LPDS plus 5 μM AY9944. This treatment reduced cellular cholesterol to ∼35% compared with untreated cells ([Figure 5A](#F5){ref-type="fig"}). Cholesterol depletion with AY9944 dispersed GS28 and GS15 ([Figure 5B](#F5){ref-type="fig"}) and reduced the level of Man II ([Figure 5C](#F5){ref-type="fig"}). Other Golgi proteins (GM130, Syn5, and p230) remained at the perinuclear region ([Figure 5B](#F5){ref-type="fig"}). The interaction of GS28 and Syn5 was also reduced ([Figure 5D](#F5){ref-type="fig"}). These phenotypes are quite similar to those in cells depleted of OSBP. AY9944 treatment caused a significant accumulation of 7-DHC in the cells ([Figure 5A](#F5){ref-type="fig"}), but addition of 7-DHC to cells had no effect on GS28 localization (unpublished data).

![Cellular cholesterol depletion mislocalizes intra-Golgi v-SNAREs (GS28 and GS15) throughout the cytoplasm. HeLa cells were grown in medium containing 10% FBS or 5% LPDS plus 5 μM AY9944 for 48 h. (A) Lipids extracted from the cells were analyzed by gas chromatography. The solid and open arrowheads indicate the peak position of cholesterol and 7-DHC, respectively. Total cholesterol (black), 7-DHC (gray), and other lipids (white) in the cells were quantified. Note the accumulation of 7-DHC in LPDS/AY9944-treated cells, which is the immediate precursor of cholesterol. (B) Cells were fixed and stained with the indicated antibodies. Scale bar, 10 μm. (C) Cell lysates were subjected to SDS--PAGE and immunoblotted with the indicated antibodies. (D) Cell lysates were immunoprecipitated with anti-GS28 antibody, and the precipitates were immunoblotted with the indicated antibodies.](3534fig5){#F5}

Implication of COP-I--mediated transport in GS28 dispersion induced by OSBP depletion
-------------------------------------------------------------------------------------

Given that GS28 and GS15 are enriched in COP-I--coated vesicles budded from the Golgi ([@B28]; [@B51]; [@B53]), we asked whether COP-I is involved in GS28 mislocalization. γ-COP, a subunit of COP-I coat, localized mainly at the Golgi in control cells ([Figure 6A](#F6){ref-type="fig"}). In contrast, γ-COP redistributed drastically from the Golgi to the cytoplasm in OSBP-depleted cells ([Figure 6A](#F6){ref-type="fig"} and Supplemental Figure S5A).

![Involvement of COP-I--mediated transport in GS28 mislocalization. (A) HeLa cells were transfected with the indicated siRNAs for 72 h. Cells were fixed and stained with anti-GM130 (green) and anti-γ-COP (red) antibodies. Scale bar, 10 μm. (B--D) Simultaneous depletion of ArfGAP1 and OSBP suppresses the GS28 dispersion induced by depletion of OSBP alone. HeLa cells were transfected with the indicated siRNAs twice. The subsequent experiments were performed 5 d after the first siRNA transfection. (B) Cell lysates were subjected to SDS--PAGE and immunoblotted with the indicated antibodies. (C, D) Cells were fixed and stained with anti-GS28 (green) and anti-Syn5 (red) antibodies (C), and the GS28 localization was quantified (D) as in [Figure 1C](#F1){ref-type="fig"}. Scale bar, 10 μm.](3534fig6){#F6}

COP-I--mediated transport can be suppressed by depletion of ArfGAP1, a key regulator of the budding process of COP-I vesicles from the Golgi ([@B21]; [@B52]; [@B1]). Simultaneous depletion of ArfGAP1 and OSBP largely restored the perinuclear Golgi localization of GS28, being colocalized with Syn5 ([Figure 6B--D](#F6){ref-type="fig"}). The level of Man II was also partly restored in these cells ([Figure 6B](#F6){ref-type="fig"}). In contrast, ArfGAP1 depletion alone did not affect GS28 localization or Man II expression.

These results, together with the observation that γ-COP is mislocalized from the Golgi by OSBP depletion, suggest that COP-I--mediated transport underlies the mislocalization of GS28 and reduction of Man II in OSBP-depleted cells. GS28 did not colocalize with γ-COP in OSBP-depleted cells (Supplemental Figure S5A). This may be because COP-I coat proteins were uncoated from COP-I vesicles before the fusion of the vesicles to the acceptor Golgi membranes ([@B45]). The mislocalized GS28 did not colocalize with the ER protein calnexin (Supplemental Figure S5B), indicating that GS28 was not mistargeted to the ER by OSBP depletion.

DISCUSSION
==========

In the present study, we demonstrate that OSBP is essential for the perinuclear Golgi localization of GS28 and GS15, two v-SNAREs involved in intra-Golgi transport. OSBP has an FFAT motif for targeting the ER through the interaction with VAPs, a PH domain for targeting the Golgi membranes through the interaction with PI4P in the Golgi, and a sterol-binding domain. We showed that these three domains in OSBP are all required for the perinuclear Golgi localization of GS28, suggesting that OSBP-dependent cholesterol transport from the ER to the Golgi is required for the Golgi localization of GS28. In addition to these domains, phosphorylation of Ser-381/384/387 of OSBP is reported to be linked to its Golgi localization ([@B27]). Because both phosphorylation-defective and mimic mutants restored the perinuclear localization of GS28 in OSBP-depleted cells, phosphorylation and dephosphorylation of these serines appear not to be involved in the Golgi v-SNARE localization. This phosphorylation site was recently extended to include Thr-379, Ser-388, and Ser-391, and an additional cluster of phosphoserine residues (Ser-192/195/200) was identified ([@B11]). Whether the newly identified phosphorylations of OSBP are involved in the Golgi v-SNARE localization needs further investigation.

OSBP participates in the recruitment of CERT from the ER to the Golgi and thereby up-regulation of sphingomyelin synthesis in the Golgi ([@B34]). CERT depletion causes the fragmentation of the Golgi, which is consistent with a previous report ([@B34]), but did not induce specific mislocalization of Golgi v-SNAREs. Furthermore, overexpression of CERT in OSBP-depleted cells did not restore the mislocalization of GS28. Thus the influence on the Golgi v-SNAREs is selectively attributable to OSBP function, not to CERT function. This function of OSBP is most likely executed by the Golgi cholesterol that is regulated by OSBP, not by the Golgi sphingolipids. The contribution of cholesterol to the GS28 localization was also supported by cellular cholesterol depletion experiment with lovastatin, an inhibitor of HMG-CoA reductase, or with AY9944, an inhibitor of 3β-hydroxysterol ∆^7^-reductase.

There is increasing evidence that cholesterol facilitates membrane fusion ([@B19]; [@B44]; [@B4]; [@B23]). For example, it was suggested that removal of cholesterol from Golgi membrane by use of MβCD inhibits the fusion step of intra-Golgi transport in a cell-free assay ([@B44]). Syntaxin1, a t-SNARE, is concentrated in large, 200-nm cholesterol-dependent clusters at the PM in PC12 cells ([@B19]). These clusters define docking and fusion sites for secretory vesicles, which suggests that a lateral clustering of transmembrane domains of t-SNARE by cholesterol is required for efficient fusion. By using reconstituted proteoliposomes, it was shown that cholesterol induces a conformational change of the v-SNARE (VAMP2) transmembrane domain from an open scissors-like dimer to a parallel dimer ([@B47]), which might give VAMP2 a more favorable shape for subsequent membrane fusion. Therefore, one possible scenario is that SNARE activity is lowered in a cholesterol-poor environment in OSBP-depleted cells, which prevents efficient fusion of v-SNARE--containing vesicles to the Golgi. The vesicles that fail to fuse with the Golgi may be eventually dispersed to the cytoplasm.

Of interest, the depletion of OSBP mislocalized not only intra-Golgi SNAREs but also γ-COP, a subunit of COP-I coat, from the Golgi to the cytoplasm. The depletion of ArfGAP1, a key regulator of the budding process of COP-I vesicles from the Golgi, restored the perinuclear Golgi localization of GS28 in OSBP-depleted cells. Thus COP-I--mediated transport may participate in the mislocalization of intra-Golgi SNAREs. As discussed earlier, inefficient fusion of COP-I vesicles to the Golgi because of the lowered SNARE activity would underlie the dispersion of GS28, GS15, and γ-COP. Of note, similar abnormalities, such as mislocalization of intra-Golgi v-SNAREs and COP-I coat from the Golgi to the cytoplasm, reduction of GS28 and Syn5 interaction, and degradation of Golgi enzymes, have been observed in cells depleted of the COG (conserved oligomeric Golgi) complex, an essential tethering factor of COP-I vesicles to the acceptor Golgi membranes ([@B32]; [@B55]; [@B41]).

In cells treated with AY9944, 7-DHC, a substrate of 3β-hydroxysterol ∆^7^-reductase, accumulated with a concomitant decrease of cholesterol. Although 7-DHC differs from cholesterol only in a double bond at the seventh position and is indistinguishable from cholesterol in its ability to become incorporated into membrane rafts, the protein composition of rafts purified from AY9944-treated rat brain tissue is altered ([@B15]). The altered Golgi raft proteins in AY9944-treated cells might be causative of the mislocalization of v-SNAREs and the reduction of Man II. Of note, deficiency of 3β-hydroxysterol ∆^7^-reductase causes Smith-Lemli-Opitz syndrome (SLOS), an autosomal recessive congenital developmental condition that includes such disorders as microcephaly and polydactyly ([@B36]). It is worth examining whether impaired COP-I vesicle transport and/or reduction of Golgi enzymes contribute to the etiology of SLOS.

MATERIALS AND METHODS
=====================

Reagents
--------

Leupeptin, aprotinin, pepstatin A, brefeldin A, cholesterol, 7-DHC, lovastatin, AY9944, and 5α-cholestane were purchased from Sigma (St. Louis, MO). Phenylmethylsulfonyl fluoride was from Wako (Osaka, Japan). Protein G Sepharose 4 Fast Flow was from GE Healthcare (Little Chalfont, UK). \[^35^S\]methionine was from Perkin Elmer-Cetus (Waltham, MA). LPDS (*d* \> 1.215 g/ml) was prepared from fetal bovine serum (FBS; purchased from Biowest \[Nuaillé, France\]) by ultracentrifugation in KBr at a density of 1.215 g/ml. After centrifugation for 45 h at 18°C using a Beckman 45 Ti rotor at 138,000 × *g*, the lipoprotein layer was removed and the bottom fraction was dialyzed (MWCO 3500; Spectrum Laboratories \[Rancho Dominguez, CA\]) against phosphate-buffered saline (PBS).

Antibodies
----------

Rabbit polyclonal antibodies were anti-Man II from Chemicon (Billerica, MA) or US Bio (Salem, MA); anti-Myc tag from Upstate (Billerica, MA); anti-Syn5 from Synaptic Systems (Goettingen, Germany); anti-CERT from Bethyl Laboratories (Montgomery, TX); and anti-ArfGAP1 from Abgent (San Diego, CA); anti-OSBP was described previously ([@B31]); anti--γ-COP was a kind gift from Rainer Duden (University of Lübeck, Lübeck, Germany). Mouse monoclonal antibodies were anti-GS28, anti-GM130, anti-p230, anti-GS15, anti-calnexin from BD Transduction (San Jose, CA); anti-Syn5 (1C5), a kind gift from Kei Suga and Kimio Akagawa (Kyorin University School of Medicine, Tokyo, Japan); anti-Myc tag (9E10), anti-actin (AC-40), and anti--α-tubulin (DM 1A) from Sigma; and anti--β-actin from Abcam (Cambridge, UK). Sheep polyclonal antibody was anti-TGN46 from Serotec (Hercules, CA). Secondary anti-rabbit immunoglobulin G (IgG)--horseradish peroxidase (HRP) and anti-mouse IgG-HRP were from GE Healthcare. Anti-rat IgG-HRP was from American Qualex (San Clemente, CA).

Cell culture
------------

HeLa cells were maintained in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS and penicillin-streptomycin-glutamine (GIBCO, Carlsbad, CA) in a 5% CO~2~ humidified 37°C cell culture incubator.

RNA interference
----------------

siRNA duplexes were synthesized by Nippon Gene (Tokyo, Japan). siRNA sequences are as follows: OSBP\#1: sense, 5′-UACUGGGAGUGUAAAGAAATT-3′; antisense, 5′-UUUCUUUACACUCCCAGUATT-3′OSBP\#2: sense, 5′-CGAACGAGCCACACUCUUUAG-3′; antisense, 5′-AAAGAGUGUGGCUCGUUCGUU-3′OSBP\#3: sense, 5′-GCGAAAUUGAUAUUGUGAAUC-3′; antisense, 5′-UUCACAAUAUCAAUUUCGCCA-3′ArfGAP1: sense, 5′-GAACCAGGAAGGUUCUUAAAG-3′; antisense, 5′-UUAAGAACCUUCCUGGUUCUU-3′CERT\#2: sense, 5′-CAUCACACCUCACGAUUUUGA-3′; antisense, 5′- AAAAUCGUGAGGUGUGAUGAC-3′

CERT\#1 was purchased from Invitrogen (Stealth RNAi, HSS115328). Control siRNA was purchased from Nippon Gene and used as a negative control. For RNA interference, cells were transfected with 20 nM specific siRNAs using Lipofectamine 2000 or Lipofectamine RNAiMAX according to the instructions of the manufacturer (Invitrogen). Forty-eight hours after siRNA transfection, if necessary, plasmids were additionally transfected by using Optifect Reagent according to the instructions of the manufacturer (Invitrogen). Unless indicated otherwise, all the subsequent experiments were performed 72 h after siRNA transfections.

cDNA constructs
---------------

Rabbit OSBP (GenBank Accession No. J05056) was obtained from ATCC and subcloned into pcDNA3-Myc vector. To generate siRNA-resistant OSBP (pcDNA3-Myc-OSBP\*), six silent mutations (underlined) were introduced into the OSBP siRNA\#1 target sequence (A[G]{.ul}TA[T]{.ul}TGGGA[A]{.ul}TG[C]{.ul}AA[G]{.ul}GA[G]{.ul}A) by PCR. OSBP mutants (R109/110E, EFFD/ALLA, ∆FFAT, S381A, S381/384/387E, and K495A) with siRNA-resistant mutations were generated by using pcDNA3-Myc-OSBP\* as a template and subcloned into pcDNA3-Myc. Human caveolin-1 (GenBank Accession No. NM_001753) cDNA was obtained by reverse transcriptase-PCR from total RNA of HeLa cells and subcloned into pEGFP-N3 vector. Human VAMP4 (GenBank Accession No. NM_003762) and human CERT cDNAs (GenBank Accession No. NM_031361) were obtained by reverse transcriptase-PCR from total RNA of HeLa cells and subcloned into pcDNA3-Myc or p3xFLAG-CMV-14 vector.

Lipid extraction
----------------

Lipid was extracted according to the Bligh and Dyer method ([@B3]). In brief, 800 μl of cell lysates was collected into screw-capped glass tubes. Three milliliters of chloroform-methanol mixture (1:2 \[vol/vol\]) was added, and the mixture was shaken vigorously for 10 min, and then 1 ml of chloroform and 1 ml of 0.9% KCl were added. The mixture was shaken vigorously again for 10 min, and the phases were separated by centrifugation at 2000 × *g* for 5 min at room temperature. The chloroform phase (lower layer) was collected and used for subsequent experiments.

Gas chromatography analysis
---------------------------

Extracted lipids were saponified at 60°C for 1 h in ethanolic KOH solution, and unsaponifiable lipids (extracted with hexane) were treated with a mixture of trimethylchlorosilane, 1,1,1,3,3,3-hexamethyldisilazane, and dried pyridine (1:3:9 \[vol:vol:vol\]) for 30 min at room temperature. The trimethylsilyl derivatives were subjected to gas chromatography analysis, using a model GS353B gas chromatograph (GL Sciences, Tokyo, Japan) equipped with a SPELCO SPB-1TM capillary column (10.25 mm × 60 m, 0.25-mm film thickness; Sigma). The oven temperature was programmed to hold at 50°C for 10 min and then rise to 280°C. The injector and detector temperatures were 300°C. The data were processed using Chromato-PRO (Run Time Corporation, Kanagawa, Japan) and normalized to the signal from the internal standard (5α-cholestane) and total cell proteins. Values were expressed as a percentage of the control. Retention times for cholesterol and 7-DHC were established with synthetic standards.

Immunofluorescence and confocal microscopy
------------------------------------------

All immunofluorescence steps were performed at room temperature, and cells were extensively rinsed with PBS after each step. HeLa cells grown on poly-[l]{.smallcaps}-lysine--coated glass coverslips were fixed with either methanol (−20°C for 10 min) or 3.7% formaldehyde (room temperature for 20 min) in PBS. Formaldehyde-fixed cells were then quenched with 50 mM NH~4~Cl in PBS for 10 min and permeabilized with either 0.5% Triton X-100 (vol/vol) for 15 min or 0.1% saponin (wt/vol) for 10 min at room temperature. The cells were blocked with 3% bovine serum albumin (BSA; Sigma) in PBS for 30 min, incubated with the primary antibodies in the same buffer, and visualized with the secondary antibodies conjugated to Alexa dyes (Molecular Probes). We used 4′,6′-diamidino-2-phenylindole (DAPI; Sigma) to stain nuclei. Confocal images were acquired at room temperature on a laser-scanning microscope (LSM510; Carl Zeiss, Oberkochen, Germany) with a 63 × 1.4 plan-Apochromat oil immersion lens using argon and HeNe lasers or a confocal laser microscope (FV1000D IX81; Olympus, Tokyo, Japan) using a 60× PlanApoN oil immersion lens (1.42 numerical aperture; Olympus). For final output, images were processed using Photoshop 7.0 software (Adobe, San Jose, CA).

Immunoblotting
--------------

Cell lysates were subjected to SDS--PAGE and transferred to nitrocellulose or polyvinylidene fluoride membranes using the Bio-Rad protein transfer system. The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.05% Tween 20 or 1% BSA in PBS and then incubated with the indicated antibodies. Proteins bound to the antibodies were visualized with an enhanced chemiluminescence kit (ECL; Amersham Biosciences, Little Chalfont, UK). For final output, images were processed using Photoshop 7.0 software.

Immunoprecipitation
-------------------

Cells were collected in ice-cold PBS by scraping and precipitated by centrifugation at 1000 × *g* for 3 min. Precipitated cells were suspended with 500 μl of immunoprecipitation (IP) buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 5 μg/ml leupeptin, 5 μg/ml pepstatin A, 5 μg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride, supplemented with 1% Triton X-100) by pipetting and incubated for 30 min on ice. The cell lysates were centrifuged at 15,000 × *g* for 20 min, and the supernatant fluid was collected. The protein concentration in each sample was quantified and normalized by adding immunoprecipitation buffer. An aliquot of the lysate was saved at this step as the input fraction. Cell lysates were precleared with 30 μl of protein G (50% slurry) for 30 min at 4°C, and the resultant lysates were again incubated with 0.5 μg of anti-GS28 antibodies and 30 μl of protein G for 2.5 h with rotating at 4°C. The immunoprecipitated complex was washed three times with 1 ml of IP buffer, mixed with 60 μl of 2 × SDS sample buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 10% 2*-*mercaptoethanol, and 0.01% bromophenol blue), and boiled at 95°C for 5 min. After centrifugation to precipitate the beads, the supernatant fraction was used for subsequent experiments.

Assay for ACAT activity
-----------------------

ACAT activity in the cells was determined by measuring the incorporation of \[^14^C\]oleic acid (American Radiolabeled Chemicals, St. Louis, MO) into cellular cholesteryl esters. Briefly, \[^14^C\]oleic acid/BSA complex was prepared as previously described ([@B10]) and added to a final concentration of 3 μCi/ml. After the incubation for 2 h, the cells were harvested as mentioned, and the lipids were extracted by the method of Bligh and Dyer ([@B3]). The lipids were then subjected to TLC on a Silica Gel 60 plate (Merck, Billerica, MA) using a mobile phase of petroleum ether/ethyl ether/acetic acid (60:40:1 \[vol/vol/vol\]). Distribution of radioactivity on the plate was quantified with a BAS1500 bioimaging analyzer (Fujix, Tokyo, Japan).

Pulse chase assay
-----------------

The pulse chase assay was performed essentially as described previously ([@B40]). Control or OSBP siRNA--treated HeLa cells were cultured in DMEM without methionine and cysteine (GIBCO) for 1 h and then pulsed with 77 μCi of \[^35^S\]methionine for 15 min. Cells were washed and chased for 0, 1, or 3 h in DMEM containing 10 mM cold methionine. Medium was collected and precipitated with trichloroacetic acid. The sample was resolved by SDS--PAGE, followed by autoradiography. For brefeldin A treatment, 5 μg/ml brefeldin A was used throughout the experiments.

Statistics
----------

Statistical analyses were performed with Student\'s *t* test, setting the significance at *p* \< 0.05.
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ACAT

:   acyl-CoA:cholesterol acyltransferase

Cav1

:   caveolin-1

COP

:   coat protein complex

7-DHC

:   7-dehydrocholesterol

FFAT

:   two phenylalanines in an acidic tract

HMG-CoA

:   3-hydroxy-3-methylglutaryl-CoA

LPDS

:   lipoprotein-deficient serum

Man II

:   mannosidase II

ORP

:   OSBP-related protein

OSBP

:   oxysterol-binding protein

PH

:   pleckstrin homology

SNARE

:   soluble *N*-ethylmaleimide-sensitive fusion attachment protein receptor

Syn5

:   syntaxin5

VAP

:   vesicle-associated membrane protein--associated protein
